Skip to content

C91.02

Billable

Acute lymphoblastic leukemia, in relapse

HCC Category Mapping

V28HCC 18Metastatic Cancer to Peritoneum and Other Specified Sites
0.368
V24HCC 8Metastatic Cancer and Acute Leukemia
2.484
ESRDHCC 8Metastatic Cancer and Acute Leukemia
0.000
RxHCCHCC 19Lymphoma and Other Cancers
0.000

What This Code Means

A fast-growing blood cancer affecting young white blood cells that has returned after a period of remission.

Coding Tips

  • Relapse indicates recurrence of disease after remission; distinguish from initial diagnosis or treatment failure
  • Document the timing of relapse and any new treatment initiated

Clinical Significance

Acute lymphoblastic leukemia in relapse indicates recurrence of blast cells in the bone marrow, blood, or extramedullary sites after achieving remission. Relapsed ALL carries a significantly worse prognosis than initial disease, with lower rates of second remission and overall survival. Treatment typically requires intensive salvage chemotherapy and consideration for stem cell transplantation as the primary curative approach.

Documentation Requirements

  • Documentation must demonstrate recurrence of blast cells exceeding 5% in bone marrow or reappearance in peripheral blood after documented remission.
  • The timing of relapse (early versus late), site of relapse (bone marrow, central nervous system, testicular, or combined), salvage treatment plan, and candidacy for stem cell transplantation must be documented.

Commonly Confused Codes

Code Hierarchy

Open C91.02 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.